aod9604 clinical trial dosage AOD-9604 Peptide AOD 9604 Peptide for Fat
Description
Always review the individual product details
That modified version became AOD-9604 (Anti-Obesity Drug 9604)
Development was ultimately discontinued after clinical results did not demonstrate sufficient efficacy to meet pharmaceutical thresholds
if it specifies oral/sublingual, the same per-dose amount is the reference point, delivered by that route instead of a syringe
Some people benefit from weekly shots, while others do better with monthly sessions
